Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.

Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.

Item
http://www.wikidata.org/entity/Q33822458
Exposure-response modeling of clinical end points using latent variable indirect response modelsPharmacodynamic models for discrete data.Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease.Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients.Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.A semi-mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first-in-human single ascending dose study.Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis.Performance of nonlinear mixed effects models in the presence of informative dropout.Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression.Continuous-time Markov modelling of flexible-dose depression trials.Information contributed by meta-analysis in exposure-response modeling: application to phase 2 dose selection of guselkumab in patients with moderate-to-severe psoriasis.Latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trials.Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasis.
P2860

Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.

Item
http://www.wikidata.org/entity/Q33822458
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Informative dropout modeling o ...... ab in patients with psoriasis.
@ast
Informative dropout modeling o ...... ab in patients with psoriasis.
@en
type
label
Informative dropout modeling o ...... ab in patients with psoriasis.
@ast
Informative dropout modeling o ...... ab in patients with psoriasis.
@en
prefLabel
Informative dropout modeling o ...... ab in patients with psoriasis.
@ast
Informative dropout modeling o ...... ab in patients with psoriasis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Informative dropout modeling o ...... ab in patients with psoriasis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698